Fidelity Investments’s Organigram Holdings OGI Stock Holding History

Fidelity Investments’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-750	Closed	-$1.91K	–	5532
2023 Q1	$1.91K	Buy	+750	New	+$2.38K	﹤0.01%	4638
2022 Q4	–	Hold	0	–	–	–	5326
2021 Q3	–	Sell	-1	Closed	–	–	4822
2021 Q2	$0	Buy	+1	New	+$11	﹤0.01%	4689

Other funds holding OGI

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments's OGI Position: Q2 2023 in Review

Fidelity Investments sold out of Organigram Holdings (OGI) in Q2 2023, closing a stake of 750 shares — an estimated $1.91K sold.

Fidelity Investments first reported a position in OGI in Q2 2021 and held it in 2 quarters. The position peaked at $1.91K in Q1 2023. 85 funds tracked by Wall St. Rank hold OGI as of Q2 2023.

Fidelity Investments reported no remaining Organigram Holdings position as of Q2 2023 after selling out during the quarter.
Fidelity Investments sold 750 Organigram Holdings shares in Q2 2023, an estimated $1.91K.
Fidelity Investments first reported a position in Organigram Holdings in Q2 2021 and held it in 2 quarters.
Fidelity Investments's Organigram Holdings position peaked at $1.91K in Q1 2023.
85 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.